This morning Roche announced they have acquired MySugr. Per a company issued press release:
“Roche (SIX: RO, ROG; OTCQX: RHHBY) and mySugr announced today that the two partners have signed an agreement under which Roche acquired all shares of mySugr GmbH. Counting more than one million users globally, mySugr is one of the leading mobile diabetes platforms in the market and will become an integral part of Roche’s new patient-centered digital health services platform in diabetes care. The acquisition allows Roche to expand its leading position in the area of diabetes management.”
This is great news for the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.